Companies · Other

Remote Medicine Inc

SEATTLE · Other

Diligence memoA one-page analyst read on Remote Medicine Inc — recommendation, valuation, rhythm, risks.
$50.7M
Total raised · real
6
Rounds
0.8×
Latest step-up
Top 8%
Sector rank · raised
Series B
Latest stage · inferred · Thu Oct 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Remote Medicine Inc looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.85× the median modeled value of Series B Other companies in 2019–2021 (371 peers) — value vs value, same stage and era.
  • Within the normal band (85% of peer median) for its niche.
Dormant
  • Last raise 5.7 yr ago; this sector typically re-raises about every 11 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other

Remote Medicine Inc is one of 25015 Other companies tracked from SEATTLE. By capital raised it ranks among the largest (ahead of 93% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
2020-10-22
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MPre-Seed · 2010-12-06 Raised $915K (real) Modeled valuation $21M (est)$915K$21MPre-Seed2010Series A · 2013-04-11 Raised $7.3M (real) Modeled valuation $110M (est)$7.3M$110MSeries A2013Series A · 2016-01-19 Raised $1.0M (real) Modeled valuation $15M (est)$1.0M$15MSeries A2016Series A · 2016-11-02 Raised $5.0M (real) Modeled valuation $76M (est)$5.0M$76MSeries A2016Series B · 2018-04-17 Raised $20M (real) Modeled valuation $332M (est)$20M$332MSeries B2018Series B · 2020-10-22 Raised $17M (real) Modeled valuation $254M (est)$17M$254MSeries B2020+$7.3M+$1.0M+$5.0M+$20M+$17MCumulative $51M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$915K · 2010
Series A$7.3M · 2013no Seed on file
Series A extension$1.0M · 2016
Series A extension$5.0M · 2016
Series B$20.0M · 2018
Series B extension$16.5M · 2020

Stages are modeled from round size (public records carry no series label). No record for: Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 75%.

Modeled valuation trajectory
$254.1M
Base estimate est.
$41.3M
Conservative case
$921.8M
Upside case
$91.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks. Directional, not a quoted figure.

Pre-Seed · modeled $21.2M · 2010-12-062010Series A · modeled $109.8M · 2013-04-11Series A · modeled $15.1M · 2016-01-19Series A · modeled $75.7M · 2016-11-02Series B · modeled $332.3M · 2018-04-17Series B · modeled $254.1M · 2020-10-222020
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
68%
Survival probability
45% low · 83% high
1.28×/yr
Annual markup
1.55×/yr upside case
5.7 yr
Elapsed time used
5.7 yr actual, capped for stale marks
general
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
24 mo
Avg between rounds
$5.1M/yr
Capital velocity
15.6 yr
On record since
2010
First round
6
Rounds on file
How it compares to the market

Benchmarked against 25015 companies in Other. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 25× above median
This company$50.7M
Sector median$2.0M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.8× of median
This company$16.5M
Sector median$19.6M
Modeled value — vs sector median (estimate, all stages) 14× above median
This company$254.1M
Sector median$17.7M

Raised more than 93% of sector peers (real $). Modeled value above 90% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #250 of 371.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0MCapital raised (log)MStar Holding Corp · Series B Raised $67.6M · modeled $645.8M (est)Chlorum Solutions Llc · Series B Raised $39.7M · modeled $627.2M (est)IFS Management Holdco, LLC · Series B Raised $37.5M · modeled $623.8M (est)Benefit Recovery Group, LLC · Series B Raised $40.0M · modeled $618.4M (est)Shenandoah Growers, Inc. · Series B Raised $74.2M · modeled $613.4M (est)Zmco Llc · Series B Raised $40.0M · modeled $610.5M (est)PathStream, Inc. · Series B Raised $38.8M · modeled $602.3M (est)MXY Holdings, LLC · Series B Raised $49.9M · modeled $597.0M (est)Ryzac, Inc. · Series B Raised $42.5M · modeled $594.3M (est)Plouton Datacenter I, Inc. · Series B Raised $35.3M · modeled $586.5M (est)Es Ei Llc · Series B Raised $35.3M · modeled $585.7M (est)Factor Law, Inc. · Series B Raised $36.3M · modeled $570.3M (est)Remote Medicine Inc (this company) Raised $50.7M · modeled $254.1M (est)Remote Medicine Inc
CompanyStageRaised · realValue · estvs peer med.
MStar Holding CorpSeries B$67.6M$645.8M2.16×
Chlorum Solutions LlcSeries B$39.7M$627.2M2.10×
IFS Management Holdco, LLCSeries B$37.5M$623.8M2.09×
Benefit Recovery Group, LLCSeries B$40.0M$618.4M2.07×
Shenandoah Growers, Inc.Series B$74.2M$613.4M2.05×
Zmco LlcSeries B$40.0M$610.5M2.04×
PathStream, Inc.Series B$38.8M$602.3M2.01×
MXY Holdings, LLCSeries B$49.9M$597.0M2.00×
Ryzac, Inc.Series B$42.5M$594.3M1.99×
Plouton Datacenter I, Inc.Series B$35.3M$586.5M1.96×
Es Ei LlcSeries B$35.3M$585.7M1.96×
Factor Law, Inc.Series B$36.3M$570.3M1.91×
Remote Medicine Inc this companySeries B$50.7M$254.1M0.85×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$915K2010-12-06$5.1M$21.2M85%
Series A$7.3M2013-04-11$33.0M$109.8M85%
Series A$1.0M2016-01-19$4.5M$15.1M85%
Series A$5.0M2016-11-02$22.7M$75.7M90%
Series B$20.0M2018-04-17$111.1M$332.3M90%
Series B$16.5M2020-10-22$91.7M$254.1M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$915K2010-12-06
    • First recorded raise — entered as Pre-Seed.
    • 17 investors on this round.
  2. Series A$7.3M2013-04-11
    • Raised again after 28 mo — slower than the ~11 mo sector norm.
    • Round 7.9× larger than the prior — scaling up.
    • 15 investors on this round.
  3. Series A$1.0M2016-01-19
    • Raised again after 33 mo — slower than the ~11 mo sector norm.
    • Round 7.3× smaller than the prior — bridge or down round.
    • Switched to Rule 506(b) (was Rule 06).
    • 11 investors on this round.
  4. Series A$5.0M2016-11-02
    • Raised 9 mo later, in step with the ~11 mo sector norm.
    • Round 5.0× larger than the prior — scaling up.
    • 13 investors on this round.
  5. Series B$20.0M2018-04-17
    • Raised again after 17 mo — slower than the ~11 mo sector norm.
    • Round 4.0× larger than the prior — scaling up.
    • 12 investors on this round.
  6. Series B$16.5M2020-10-22
    • Raised again after 30 mo — slower than the ~11 mo sector norm.
    • Round roughly the size of the prior one.
Intelligence
2022 ~Q4
Modeled next raise · ~24mo cadence
$16.5M
Modeled next size est.range $16.5M$26.4M
0.8×
Last step-up
$5.1M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Greg Clark5 other2013-04
Wayne Wager5 other2016-01
Bill Davis2 other2013-04
Gregory Clark2 other2016-01
Scott Shapiro2 other2010-12
Brandon Baty1 other2016-01
Marc Droppert1 other2013-04
Nate McLemore1 other2013-04
Nathan McLemore1 other2016-01
Patrick Phelan1 other2020-10
Paul Budak1 other2020-10
Andrew Cull2010-12
Brad MacLean2020-10
Brian Vincent2013-04
Christopher Kenney2010-12
Doug Grady2010-12
Ingrid Onstad2020-10
Jayson Eversgerd2016-01
Jon Adams2016-01
Kelley DeConciliis2016-01
Kevin Barber2013-04
Melissa Cull2010-12
Registry & provenance

Remote Medicine Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1508320
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
project44 Holdings CorpOtherSeries B$51.1M$291.6Msame sector · same stage
Livepeer, Inc.OtherSeries B$51.2M$232.3Msame sector · same stage
ClearFlame Engines, Inc.OtherSeries B$49.6M$276.4Msame sector · same stage
FLRish, Inc.OtherSeries B$52.1M$242.9Msame sector · same stage
Hint IncOtherSeries B$48.6M$271.1Msame sector · same stage
Akerna Corp.OtherSeries B$48.6M$219.1Msame sector · same stage
Alert Holding Company, Inc.OtherSeries B$48.4M$270.9Msame sector · same stage
PropelPLM, Inc.OtherSeries B$48.2M$262.2Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
RemoteMD International, Inc.Hospitals and PhysiciansSeed$26.8M88%
Remote Care Partners, Inc.HealthtechSeries B$5.1M85%
Network of Virtual Physicians, Inc.Other TechnologySeed$3.2M84%
Remote Students, Inc.OtherSeed$49.7M84%
SOC Telemed, Inc.Other Health CareSeries C$1.9B84%
OneMedNet CorpOtherSeries A$20.8M84%
Remotely, Inc.Other TechnologySeed$8.2M83%
Med-X, Inc.OtherSeries A$32.5M83%
Frequently asked
How much funding has Remote Medicine Inc raised?
Remote Medicine Inc has raised approximately $50.7M in disclosed capital across 6 recorded financing rounds, aggregated from public filings.
What is Remote Medicine Inc's estimated valuation?
Provath's modeled valuation for Remote Medicine Inc is approximately $254.1M (modeled range $41.3M–$921.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Remote Medicine Inc at?
Remote Medicine Inc's latest modeled financing stage is Series B. Its most recent recorded round closed around Thu Oct 22.
What does Remote Medicine Inc do and where is it based?
Remote Medicine Inc operates in the Other sector, based in SEATTLE.
Explore related

See where Remote Medicine Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Remote Medicine Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.